Blood–Brain Barrier-Crossing Photo-oxygenation Nanocomposite for the Selective Mapping and Disassembly of Amyloid-β Aggregates In Vivo
Source abstract
Abstract
The accumulation of toxic amyloid-β (Aβ) aggregates in the brain underlies neuronal death and subsequent irreversible neurodegeneration in Alzheimer’s disease (AD). Currently, optimized theranostic probes targeting Aβ aggregates are still rare. Herein, we synthesized a series of tetraphenylethylene (TPE) derivatives for the selective recognition and photo-oxygenation of Aβ aggregates. Among them, TPE-yne-Indo with a strong electron-withdrawing group (benzo[e]indolium) and an electron-donating group ( N,N -dimethylaniline) can selectively recognize Aβ aggregates in solution ( K d = 310.5 nM, S/N = 6.1) and mapping Aβ plaques in brain slices. Theoretical calculations indicated that TPE-yne-Indo engaged in hydrophobic interactions with the amino acid residues Val-18 (V), Ala-21 (A), and His-13 (H) of Aβ. Notably, the binding with Aβ aggregates bestowed TPE-yne-Indo with higher reactive oxygen species (ROS) generation ability, boosting the photodynamic oxidation of Aβ aggregates. Furthermore, therapeutic nanocomposite with the lactoferrin receptor ligand (MSN@Lf&TPE-yne-Indo) was prepared to facilitate the blood–brain barrier (BBB) crossing process. In vivo assays showed that MSN@Lf&TPE-yne-Indo can selectively stain Aβ plaques and reduce Aβ deposition in the brain of APP/PS1 mice, alleviating symptoms of cognitive impairment and memory loss. This study provides a promising tool for the early diagnosis and treatment of AD.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Supramolecular Self-Assembly in Materials · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Chemical Resource Engineering, College of Chemistry
Beijing University of Chemical Technology
College of Chemistry
Beijing Normal University
Funding
Natural Science Foundation of Beijing Municipality · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Interdisciplinary Research Center of Beijing University of Chemical Technology
References (35)
Show source-provided references
1. 10.1002/cm.2182210.1002/cm.21822 ↗
2. 10.1016/j.cub.2018.04.08010.1016/j.cub.2018.04.080 ↗
3. 10.1039/C7CS00372B10.1039/C7CS00372B ↗
4. 10.1021/acs.chemrev.3c0077810.1021/acs.chemrev.3c00778 ↗
5. 10.1016/j.ejmech.2019.04.06910.1016/j.ejmech.2019.04.069 ↗
6. 10.1021/jm070025+10.1021/jm070025+ ↗
7. 10.1016/j.bmc.2018.05.00110.1016/j.bmc.2018.05.001 ↗
8. 10.1039/C8CC10166C10.1039/C8CC10166C ↗
9. 10.1016/j.bionps.2023.10006310.1016/j.bionps.2023.100063 ↗
10. 10.1016/j.arr.2015.12.00810.1016/j.arr.2015.12.008 ↗
11. 10.1016/j.bios.2016.09.06710.1016/j.bios.2016.09.067 ↗
12. 10.1016/j.cclet.2023.10832110.1016/j.cclet.2023.108321 ↗
13. 10.1016/j.ccr.2024.21600210.1016/j.ccr.2024.216002 ↗
14. 10.1021/acs.jmedchem.1c0161910.1021/acs.jmedchem.1c01619 ↗
15. 10.1002/adhm.20230073310.1002/adhm.202300733 ↗
16. 10.1039/C8QM00209F10.1039/C8QM00209F ↗
17. 10.1093/nsr/nwab01310.1093/nsr/nwab013 ↗
18. 10.1021/jacs.8b1282010.1021/jacs.8b12820 ↗
19. 10.1007/s11426-021-1113-010.1007/s11426-021-1113-0 ↗
20. 10.1002/cmdc.20240022310.1002/cmdc.202400223 ↗
21. 10.1016/j.ccr.2023.21537510.1016/j.ccr.2023.215375 ↗
22. 10.1021/jacs.9b1063210.1021/jacs.9b10632 ↗
23. 10.1093/brain/awab05810.1093/brain/awab058 ↗
24. 10.1016/j.actbio.2021.01.01810.1016/j.actbio.2021.01.018 ↗
25. 10.1002/anie.20150431010.1002/anie.201504310 ↗
26. 10.1021/acsnano.4c1488710.1021/acsnano.4c14887 ↗
27. 10.1021/acs.analchem.4c0184510.1021/acs.analchem.4c01845 ↗
28. 10.1007/s40242-024-3256-910.1007/s40242-024-3256-9 ↗
29. 10.1016/j.dyepig.2020.10891010.1016/j.dyepig.2020.108910 ↗
30. 10.1021/acschembio.3c0018310.1021/acschembio.3c00183 ↗
31. 10.1021/jacs.6b0512910.1021/jacs.6b05129 ↗
32. 10.1039/D1OB01677F10.1039/D1OB01677F ↗
33. 10.1021/acs.molpharmaceut.6b0081910.1021/acs.molpharmaceut.6b00819 ↗
34. 10.1021/acs.analchem.1c0228910.1021/acs.analchem.1c02289 ↗
35. 10.1002/anie.20221155010.1002/anie.202211550 ↗